Non-NMDA receptor antagonist GYKI 52466 suppresses cortical after discharges in immature rats

European Journal of Pharmacology

Volumn 333, Issue 1, 1997, Pages 17-26

  Kubová, Hana ^a   Világi, Ildiko ^a   Mikulecká, Anna ^a   Mareš, Pavel ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Anticonvulsant action; Excitatory amino acid; Flumazenil; GYKI 52466 (1 (4 aminophenyl) 4 methyl 7,8 methylendioxy 5H 2,3 benzo diazepine); Motor system

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; FLUMAZENIL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ANXIETY; ARTICLE; BEHAVIOR; CLONIC SEIZURE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; CEREBRAL CORTEX; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPSY, TONIC-CLONIC; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; MALE; MOTOR SKILLS; MUSCULOSKELETAL EQUILIBRIUM; RATS; RATS, WISTAR; RECEPTORS, AMPA;

EID: 0342762024     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01119-9     Document Type: Article

References (53)

1. Altman J., Sudarshan K. Postnatal development of locomotion in the laboratory rat. Anim. Behav. 23:1975;896-920.
2. Berzsenyi P., Tarnawa I., Farkas S., Andrási F. Pharmacology of a new centrally acting muscle relaxant. Pharmacol. Res. Commun. 20 (Suppl. 1):1988;139-140.
3. Block F., Schwarz M. The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors. Eur. J. Pharmacol. 256:1994;149-153.
4. Bonetti E.P., Pieri L., Cumin R., Pieri M., Gamzu E.R., Muller R.K.M., Haefely W. Benzodiazepine antagonist Ro 15-1788: Neurological and behavioral effects. Psychopharmacology. 78:1982;8-18.
5. Box G.E.P., Cox D.R. Analysis of transformations. J. R. Stat. Soc. Ser. B: 26:1964;211-252.
6. Chapman, A.G., 1991. Excitatory amino acid antagonists and therapy of epilepsy. In: Meldrum, B.S. (Ed.), Excitatory Amino Acid Antagonists. Blackwell Scientific Publications, London, pp. 265-286.
7. Chapman A.G., Smith S.E., Meldrum B.S. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res. 9:1991;92-96.
8. Dantzer R., Pério A. Behavioural evidence for partial agonist properties of Ro 15-1788, a benzodiazepine receptor antagonist. Eur. J. Pharmacol. 81:1982;655-658.
9. Danysz W., Essmann U., Bresink I., Wilke R. Glutamate antagonists have different effects on spontaneous locomotor activity in rats. Pharmacol. Biochem. Behav. 48:1994;111-118.
10. Dixon, W.J. (Ed.), 1990. BMDP Statistical Software. UCLA Press, Los Angeles.
11. Donevan S.D., Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
12. Dürmüller N., Craggs M., Meldrum B.S. The effect of non-NMDA antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17:1994;167-174.
13. Engel, J., Jr., 1992. Experimental animal models of epilepsy: Classification and relevance to human epileptic phenomena. In: Avanzini, G., Engel, J., Jr., Fariello, R., Heinemann, U. (Eds.), Neurotransmitters in Epilepsy. Elsevier, Amsterdam, pp. 9-20.
14. Farkas S., Ono H. Participation of NMDA and non-NMDA excitatory amino acid receptors in the mediation of spinal reflex potentials in rats: An in vivo study. Br. J. Pharmacol. 114:1995;1193-1205.
15. Freeman, J.M., 1995. A clinician's look at the developmental neurobiology of epilepsy. In: Schwartzkroin, P.A., Moshe, S.L., Noebels, J.L., Swann J.W. (Eds.), Brain Development and Epilepsy. Oxford University Press, New York, pp. 9-33.
16. Haefely, W., 1989. Benzodiazepines: Mechanisms of action. In: Levy, R.H., Dreifuss, F.E., Mattson, R.H., Meldrum, B.S., Penry, J.K. (Eds.), Antiepileptic Drugs, 3rd ed. Raven Press, New York, pp. 721-734.
17. Headley P.M., Grillner S. Excitatory amino acids and synaptic transmission: The evidence for a physiological function. Trends Pharmacol. Sci. 11:1990;205-211.
18. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Stat. 6:1979;56-70.
19. Honoré, T., 1991. Inhibitors of kainate and AMPA ionophore receptors. In: Meldrum, B.S. (Ed.), Excitatory Amino Acid Antagonists. Blackwell, Oxford, pp. 180-194.
20. Hunkeler W., Mohler H., Pieri L., Polc P., Bonetti E.P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 290:1981;514-516.
21. Insel T.R., Miller L.P., Gelhard R.E. The ontogeny of excitatory amino acid receptors in rat forebrain. I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience. 35:1990;31-43.
22. Kubová H., Mareš P. Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats. Pharmacol. Biochem. Behav. 52:1995;489-492.
23. Kubová H., Makal V., Miòová M., Vaòková S., Mareš P. Influence of clonazepam on cortical epileptic afterdischarges in rats. Arch. Int. Pharmacodyn. 307:1990;49-59.
24. Kubová H., Mareš P., Vorlíèek J. Stable anticonvulsant action of benzodiazepines during development in rats. J. Pharm. Pharmacol. 45:1993;807-810.
25. Kubová H., Mocková M., Lanštiaková M., Mareš P., Vorlíèek J. Pharmacology of cortical epileptic afterdischarges in rats. Epilepsia. 37:1996;336-341.
26. Löscher W., Hönack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: Comparison with diazepam and interactions with flumazenil. Br. J. Pharmacol. 113:1994;1349-1357.
27. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 34 (Suppl. 5):1993;S1-S8.
28. Makal V., Miòová M., Kubová H., Mareš P. Developmental changes of thresholds for cortical epileptic afterdischarges. Physiol. Res. 42:1993;49-52.
29. Mandema J.W., Gubbens-Stibbe J.N., Danhof M. Stability and pharmacokinetics of flumazenil in the rat. Psychopharmacology. 103:1991;384-387.
30. Mareš P., Lanštiaková M., Vaòková S., Kubová H., Velíšek L. Ketamine blocks cortical epileptic afterdischarges but not paired-pulse and frequency potentiation. Neuroscience. 50:1992;339-344.
31. Mareš, P., Mikulecká, A., Pometlová, M., in press. Anticonvulsant action of NBQX in immature rats: Comparison with the effects on motor performance. J. Pharmacol. Exp. Ther.
32. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
33. Meldrum B.S., Craggs M.D., Dürmüller N., Smith S.E., Chapman A.G. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res. 9 (Suppl.):1992;307-311.
34. Miller L.P., Johnson A.E., Gelhard R.E., Insel T.R. The ontogeny of excitatory amino acid receptors in the rat forebrain. II. Kainic acid receptors. Neuroscience. 35:1990;45-51.
35. Monyer H., Seeburg P.H., Wisden W. Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing. Neuron. 6:1991;799-810.
36. Ouardouz M., Durand J. GYKI 52466 antagonizes glutamate responses but not NMDA and kainate responses in rat abducens motoneurones. Neurosci. Lett. 125:1991;5-8.
37. Polášek R., Kubová H., Šlamberová R., Mareš P., Vorlíèek J. Suppression of cortical epileptic afterdischarges in developing rats by anticonvulsants increasing GABAergic inhibition. Epilepsy Res. 25:1996;177-184.
38. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizures. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
39. Racine R.J., Burnham W., Gartner J., Levitan D. Rates of motor seizure development in rats subjected to electrical brain stimulation: Strain and interstimulus interval effects. Electroencephalogr. Clin. Neurophysiol. 35:1973;553-556.
40. Rathouská J., Kubová H., Mareš P., Vorlíèek J. Anticonvulsant activity of flumazenil in rats during ontogenetic development. Pharmacol. Biochem. Behav. 44:1993;581-586.
41. Rogawski M.A. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14:1993;325-331.
42. Sato M., Racine R.J., McIntyre D.C. Kindling: Basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol. 76:1990;459-472.
43. Schoepp D.D., Gamble A.Y., Salhoff C.R., Johnson B.G., Ornstein P.L. Excitatory amino acid-induced convulsions in neonatal rats mediated by distinct receptor subtypes. Eur. J. Pharmacol. 182:1990;421-427.
44. Shaw C., Lanius R.A. Cortical AMPA receptors: Age-dependent regulation by cellular depolarization and agonist stimulation. Develop. Brain Res. 68:1992;225-231.
45. Sheardown M.J., Nielsen E.O., Hansen A.J., Jacobsen P., Honoré T. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science. 247:1990;571-574.
46. Smith S.E., Dürmüller N., Meldrum B.S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201:1991;179-183.
47. Tarnawa I., Farkas S., Berzsenyi P., Pataki A., Andrasi F. Electrophysiological studies with a 2,3-benzodiazepine muscle relaxant: GYKI 52466. Eur. J. Pharmacol. 167:1989;193-199.
48. Tarnawa, I., Engberg, I., Flatman, J.A., 1990. GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. In: Lubec, G., Rosenthal, G.A. (Eds.), Amino Acids: Chemistry, Biology and Medicine. ESCOM Science Publishers, Leiden, pp. 538-546.
49. Tarnawa I., Molnar P., Gaal L., Andrasi F. Inhibition of hippocampal field potentials by GYKI 52466 in vitro and in vivo. Acta Physiol. Hung. 79:1992;163-169.
50. Winer, B.J., 1971. Statistical Principles in Experimental Design. McGraw-Hill, New York.
51. Woodbury, D.M., 1972. Applications to drug evaluations. In: Purpura, D.P., Penry, J.K., Tower, D., Woodbury, D.M., Walter, R. (Eds), Experimental Models of Epilepsy. Raven Press, New York, pp. 557-583.
52. Yamaguchi S., Donevan S.D., Rogawski M.A. Anticonvulsant activity of AMPA/kainate antagonists: Comparison of GYKI 52466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res. 15:1993;179-184.
53. Zorumski C.F., Yamada K.A., Price M.T., Olney J.W. A benzodiazepine recognition site associated with the non-NMDA glutamate receptor. Neuron. 10:1993;61-67.